The Microneedle Drug Delivery Systems Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Microneedle Drug Delivery Systems Market:
According to The Business Research Company’s Microneedle Drug Delivery Systems Global Market Report 2024, The microneedle drug delivery systems market size has grown rapidly in recent years. It will grow from $4.32 billion in 2023 to $5.13 billion in 2024 at a compound annual growth rate (CAGR) of 18.7%. The growth in the historic period can be attributed to pain-free drug delivery, enhanced patient compliance, chronic disease management, cosmetic and aesthetic applications, vaccine administration.
The microneedle drug delivery systems market size is expected to see rapid growth in the next few years. It will grow to $9.82 billion in 2028 at a compound annual growth rate (CAGR) of 17.6%. The growth in the forecast period can be attributed to cosmetic and aesthetic applications, emerging therapies, pediatric and geriatric use, global health initiatives, point-of-care testing. Major trends in the forecast period include smart microneedles, advancements in material science, advancements in wearable technology, biodegradable materials, continuous glucose monitoring.
The increase in research and demand for the vaccination process are predicted to drive the microneedle drug delivery systems market growth. Researchers view microneedle as an alternative way to inject vaccines where the receiver of the vaccine is expected to not feel any sensation of pain. Microneedle patches vaccine was developed initially for flu and measles; however, the technology is now being used increasingly for delivery of COVID-19 vaccine as well. According to a Bloomberg report, more than 3.98 billion doses of vaccine have been administered across 180 countries until July 2021. Increased demand from government and health research and development bodies for microneedle drug delivery technology propels the market for the growth of microneedle drug delivery systems market going forward.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=5338&type=smp
The microneedle drug delivery systems market covered in this report is segmented –
1) By Technology: Hollow, Porous, Solid, Other Technologies
2) By Application: Drug Delivery, Vaccine Delivery, Other Applications
3) By End-User: Diagnostics Laboratories, Life Sciences, Research Laboratories, Hospitals, Ambulatory Surgical Centers, Other End-Users
Major companies operating in microneedle drug delivery systems are focusing on innovating products, such as the MicronJet 600, to provide reliable services to customers. MicronJet 600 is used as a microneedle drug delivery system for vaccines, drugs, peptides, and dermal fillers. For instance, in November 2021, NanoPass Technologies Ltd., a US-based company that develops painless intradermal delivery solutions for vaccines and drugs, launched MicronJet 600. The MicronJet 600 is a microneedle-based device for intradermal drug delivery. It is the first and only true (<1 mm) microneedle to receive Food and Drug Administration (FDA) clearance as an intradermal delivery device for delivery below the surface of the skin.
The microneedle drug delivery systems market report table of contents includes:
1. Executive Summary
2. Microneedle Drug Delivery Systems Market Characteristics
3. Microneedle Drug Delivery Systems Market Trends And Strategies
4. Microneedle Drug Delivery Systems Market – Macro Economic Scenario
5. Global Microneedle Drug Delivery Systems Market Size and Growth
.
.
.
26. South America Microneedle Drug Delivery Systems Market
27. Brazil Microneedle Drug Delivery Systems Market
28. Middle East Microneedle Drug Delivery Systems Market
29. Africa Microneedle Drug Delivery Systems Market
30. Microneedle Drug Delivery Systems Market Competitive Landscape And Company Profiles
Top Major Players:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Overview and Scope A preclinical asset refers to all clinical trial supplies or equipment for…
Overview and Scope Hidradenitis suppurativa (HS) is a chronic skin condition that causes painful lumps…
Overview and Scope Cerebral palsy (CP) is an array of neurological illnesses that develop in…
Overview and Scope Artificial intelligence (AI) in accounting refers to the application of AI to…
Overview and Scope Alopecia areata, also known as spot baldness, refers to an autoimmune disorder…
Overview and Scope Artificial intelligence (AI) in education refers to applying AI in the classroom…